2001 and Pharmaceutical Manufacturing

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2001

Pharmaceutical Manufacturing

Preliminary Injunction Decision in Chambers of Commerce Case Provides First Insights Into Merits of Medicare Negotiations Cases

FDA Law Blog: Biosimilars

OCTOBER 4, 2023

Engler , a 2001 decision by the Sixth Circuit Court of Appeals. The court did not make much of Plaintiff’s argument that a manufacturer cannot terminate its participation in Medicare for close to two years, see Motion at 8; Complaint at 27-28, potentially dismissing it as a mere administrative matter.

Drug Pricing

Drug Pricing Pharmaceutical Manufacturing Immunity Immunization

How to approach die plate adhesion during tableting

European Pharmaceutical Review

OCTOBER 23, 2023

1 In pharmaceutical manufacturing, the high level of final product quality is the major driver. Tablets should be defect-free and compliant to good manufacturing practice (GMP) aspects and final-user requirements. Pharmaceutical Technology. 2001; 4(1), 1-33 Giatti F et al., International Journal of Food Properties.

Compounding

Compounding Pharmaceutical Manufacturing

Pharmacist Digest

Preliminary Injunction Decision in Chambers of Commerce Case Provides First Insights Into Merits of Medicare Negotiations Cases

How to approach die plate adhesion during tableting

Stay Connected